UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.

Grieve, R; Roberts, J; Wright, M; Sweeting, M; DeAngelis, D; Rosenberg, W; ... Thomas, H; + view all (2006) Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Gut , 55 (9) 1332 - 1338. 10.1136/gut.2005.064774.

Full text not available from this repository.

Abstract

For patients with mild chronic hepatitis C the cost effectiveness of antiviral therapy is unknown.

Type:Article
Title:Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C.
Location:England
DOI:10.1136/gut.2005.064774
Language:English
Additional information:PMCID: PMC1860032
Keywords:Adult, Aged, Antiviral Agents, Cost-Benefit Analysis, Disease Progression, Drug Costs, Drug Therapy, Combination, Great Britain, Health Care Costs, Hepatitis C, Chronic, Humans, Interferon-alpha, Middle Aged, Models, Econometric, Polyethylene Glycols, Quality of Life, Quality-Adjusted Life Years, Recombinant Proteins, Ribavirin, Severity of Illness Index

Archive Staff Only: edit this record